CANADA LIFE ASSURANCE Co Purchases 18,687 Shares of The Clorox Company (NYSE:CLX)

CANADA LIFE ASSURANCE Co grew its position in shares of The Clorox Company (NYSE:CLX) by 15.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 141,622 shares of the company’s stock after buying an additional 18,687 shares during the quarter. CANADA LIFE ASSURANCE Co owned 0.11% of Clorox worth $21,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of CLX. Venturi Wealth Management LLC increased its stake in shares of Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 145 shares in the last quarter. Northwest Financial Advisors purchased a new stake in shares of Clorox in the 4th quarter worth $29,000. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox in the 4th quarter worth $29,000. First United Bank & Trust purchased a new stake in shares of Clorox in the 4th quarter worth $31,000. Finally, GoalVest Advisory LLC purchased a new stake in shares of Clorox in the 1st quarter worth $31,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 0.4 %

CLX opened at $133.35 on Friday. The firm has a 50-day simple moving average of $133.73 and a two-hundred day simple moving average of $142.70. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a market capitalization of $16.56 billion, a PE ratio of 69.09, a price-to-earnings-growth ratio of 1.95 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the firm earned $1.51 EPS. The business’s revenue was down 5.3% on a year-over-year basis. Analysts forecast that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Citigroup reduced their price objective on Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. DA Davidson restated a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th. TD Cowen started coverage on Clorox in a research note on Tuesday. They issued a “sell” rating and a $122.00 price target for the company. Finally, BNP Paribas started coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target for the company. Six equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $142.13.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.